Effects of a Novel Cognitive Enhancer, Spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3 H)-one (ZSET1446), on Learning Impairments Induced by Amyloid-β1–40 in the RatYoshimasa Yamaguchi, Toshitaka Nabeshima, Hyoung‐Chun Kim et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 77
Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†Akira Kawai, Kazuo Isu, Nobuhito Araki et al.|Japanese Journal of Clinical Oncology|2016Cited by 67